Skip to main content

Advertisement

SpringerLink
Log in

Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

Hyperuricemia is associated with cardiovascular and renal diseases, as glomerulosclerosis. Noncrystalline uric acid induces deleterious effects on endothelial and vascular smooth muscle cells. In the present study, we analyzed the damage induced by UA on human mesangial cells (HMC), the potential mechanism involved in this injury, and its consequences during infection. HMC were exposed to noncrystalline UA (8 mg/dl) and/or lipopolysaccharide (LPS, 100 μg/ml) for 24 h. In the experiments of cellular viability, HMC were exposed to 8–50 mg/dl of UA. Necrosis was assessed by acridine orange and ethidium bromide. Reactive oxygen species (ROS) were analyzed by 2′,7′-dichlorofluorescein. Prostaglandin E2 (PGE2) was evaluated by ELISA. Cyclooxygenase 2 (COX-2) expression was assessed by real-time PCR. UA induced necrosis only at supraphysiological concentrations. Nevertheless, it significantly increased ROS production at 8 mg/dl. LPS increased necrosis and ROS production. Interestingly, the association between UA and LPS decreased ROS and necrosis. UA associated or not with LPS induced COX-2 expression and PGE2 increases in HMC. Results suggest that UA has pro- and anti-oxidant effects in HMC. During infections, it acts like scavenger increasing cellular viability, but alone it can induce ROS production and cellular death in higher concentrations. Additionally, UA has direct pro-inflammatory effects inducing COX-2 expression and PGE2 synthesis. It is concluded that elevated concentrations of uric acid potentially contributes to glomerular damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78(11):6858–6862

    Article  CAS  PubMed  Google Scholar 

  2. Selby JV, Friedman GD, Quesenberry CP Jr (1990) Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 131(6):1017–1027

    CAS  PubMed  Google Scholar 

  3. Emmerson BT, Row PG (1975) An evaluation of the pathogenesis of the gout kidney. Kidney Int 8:65–71

    Article  CAS  PubMed  Google Scholar 

  4. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41(6):1183–1190

    Article  CAS  PubMed  Google Scholar 

  5. Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study. 1971–1992 National Health and Nutrition Examination Survey. JAMA 283(18):2404–2410

    Article  CAS  PubMed  Google Scholar 

  6. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164(14):1546–1551

    Article  CAS  PubMed  Google Scholar 

  7. Kang DH, Park SK, Lee IK, Johnson RJ (2005) Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553–3562

    Article  CAS  PubMed  Google Scholar 

  8. Rao GN, Corson MA, Berk BC (1991) Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet derived growth factor A-chain expression. J Biol Chem 266:8604–8608

    CAS  PubMed  Google Scholar 

  9. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ (2002) Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:F991–F997

    CAS  PubMed  Google Scholar 

  10. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739–1742

    Article  PubMed  Google Scholar 

  11. Han HJ, Lim MJ, Lee YJ, Lee JH, Yang IS, Taub M (2007) Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kB. Am J Physiol Renal Physiol 292:F373–F381

    Article  CAS  PubMed  Google Scholar 

  12. Lin SD, Tsai DH, Hsu SR (2006) Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 69(11):512–516

    Article  CAS  PubMed  Google Scholar 

  13. Talbott JH, Terplan KL (1960) The kidney in gout. Medicine 39:405–467

    Article  CAS  PubMed  Google Scholar 

  14. Gonick HC, Rubini MD, Gleason IO, Sommers SC (1965) The renal lesion in gout. Ann Int Med 62:667–674

    CAS  PubMed  Google Scholar 

  15. Sohshang HL, Singh MA, Singh NG, Singh SR (2000) Biochemical and bacteriological study of urinary calculi. J Commun Dis 32(3):216–221

    CAS  PubMed  Google Scholar 

  16. Banas B, Luckow B, Möller M, Klier C, Nelson PJ, Schadde E, Brigl M, Halevy D, Holthöfer H, Reinhart B, Schlöndorff D (1999) Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol 10(11):2314–2322

    CAS  PubMed  Google Scholar 

  17. Ubezio P, Civoli F (1994) Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radic Biol Med 16:509

    Article  CAS  PubMed  Google Scholar 

  18. Seim S (1982) Production of reactive oxygen species and chemiluminescence by human monocytes during differentiation and lymphokine activation in vitro. Acta Pathol Microbiol Immunol Scand C 90(3):179–185

    CAS  PubMed  Google Scholar 

  19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin-Phenol reagents. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  20. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-∆∆CT method. Methods 25:402

    Article  CAS  PubMed  Google Scholar 

  21. Keane WF, Gekker G, Schlievert PM, Peterson PK (1986) Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin. Am J Pathol 122(1):169–176

    CAS  PubMed  Google Scholar 

  22. Sautin YY, Johnson RJ (2008) Uric Acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 27(6):608–619

    Article  CAS  PubMed  Google Scholar 

  23. Gersch C, Palii SP, Imaram W, Kim KM, Kammanchi SA, Angerhofer A, Johnson RJ, Henderson GN (2009) Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids 28(2):118–149

    Article  CAS  PubMed  Google Scholar 

  24. Berger L, Yu T (1975) Renal function in gout: IV: an analysis of 524 gouty subjects including long-term follow-up studies. Am J Med 59:605–613

    Article  CAS  PubMed  Google Scholar 

  25. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ (2002) A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13:2888–2897

    Article  CAS  PubMed  Google Scholar 

  26. MacKinnon KL, Molnar Z, Lowe D, Watson ID, Shearer E (1999) Measures of total free radical activity in critically ill patients. Clin Biochem 32(4):263–268

    Article  CAS  PubMed  Google Scholar 

  27. Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, Shieh CC, Chen MF (2006) Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 10(1):R36–R43

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was aided by grants from Conselho Nacional de Desenvolvimento Científico Tecnológico (CnPQ), Financiadora de Estudos e Projetos (FINEP), Fundação Oswaldo Ramos (FOR), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) e Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

Author information

Authors and Affiliations

  1. Nephrology Division, Department of Medicine, Federal University of São Paulo (UNIFESP), Rua Pedro de Toledo 740, 2° andar, São Paulo, CEP 04023-900, Brazil

    M. S. Convento, E. Pessoa, M. A. Dalboni, F. T. Borges & N. Schor

Authors
  1. M. S. Convento
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Pessoa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. Dalboni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. T. Borges
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Schor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Schor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Convento, M.S., Pessoa, E., Dalboni, M.A. et al. Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage. Urol Res 39, 21–27 (2011). https://doi.org/10.1007/s00240-010-0282-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-010-0282-5

Keywords

Search

Navigation